About Technology Issues FAQ

Links

Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression

Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.